Upregulation of heme oxygenase-1 potentiates EDH-type relaxations in the mesenteric artery of the spontaneously hypertensive rat

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 10, 2013, Pages

  Li, Zhuoming ^a   Wang, Yu ^a   Man, Ricky Y K ^a   Vanhoutte, Paul M ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Chonbuk National University   (South Korea)

Author keywords

Bilirubin; Endothelium dependent hyperpolarization; Heme oxygenase 1; Hemin; Na+ K+ atpase

Indexed keywords

1 [(2 CHLOROPHENYL)DIPHENYLMETHYL] 1H PYRAZOLE; APOCYNIN; CARBON MONOXIDE; HEME OXYGENASE 1; HEMIN; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; OUABAIN; PROTOPORPHYRIN ZINC; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CONDUCTANCE; CONTROLLED STUDY; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION; HYPERPOLARIZATION; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; VASODILATATION;

BILIRUBIN; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION; HEME OXYGENASE-1; HEMIN; NA+-K+-ATPASE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BILIRUBIN; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HEME OXYGENASE (DECYCLIZING); HEMIN; HYPERTENSION; MALE; MESENTERIC ARTERIES; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; SODIUM-POTASSIUM-EXCHANGING ATPASE; UP-REGULATION; VASODILATION; VASODILATOR AGENTS;

EID: 84887590359     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00962.2012     Document Type: Article

References (69)

1. Abraham NG, Kappas A. Mechanism of heme-heme oxygenase system impairment of endothelium contraction in the spontaneously hypertensive rat. Hypertension 58: 772-773, 2011.
2. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127, 2008.
3. Andrews KL, Irvine JC, Tare M, Apostolopoulos J, Favaloro JL, Triggle CR, Kemp-Harper BK. A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries. Br J Pharmacol 157: 540-550, 2009.
4. +2-subunit expression as well as short- and long-term work capacity in humans. J Appl Physiol 107: 1771-1780, 2009.
5. Barry-Lane PA, Patterson C, van der Merwe M, Hu ZY, Holland SM, Yeh ETH, Runge MS. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 108: 1513-1522, 2001.
6. Brahler S, Kaistha A, Schmidt VJ, Wolfle SE, Busch C, Kaistha BP, Kacik M, Hasenau AL, Grgic I, Si H, Bond CT, Adelman JP, Wulff H, de Wit C, Hoyer J, Kohler R. Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension. Circulation 119: 2323-2332, 2009.
7. Campbell WB, Fleming I. Epoxyeicosatrienoic acids and endotheliumdependent responses. Pflügers Arch 459: 881-895, 2010.
8. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
9. Chen G, Suzuki H, Weston AH. Acetylcholine releases endotheliumderived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol 95: 1165-1174, 1988.
10. Chok MK, Ferlicot S, Conti M, Almolki A, Durrbach A, Loric S, Benoit G, Droupy S, Eschwege P. Renoprotective potency of heme oxygenase-1 induction in rat renal ischemia-reperfusion. Inflamm Allergy Drug Targets 8: 252-259, 2009.
11. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278: H643-H651, 2000.
12. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidasederived oxidative stress. Hypertension 50: 636-642, 2007.
13. Dhein S. Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol Sci 19: 229-241, 1998.
14. Dora KA, Gallagher NT, McNeish A, Garland CJ. Modulation of endothelial cell KCa3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries. Circ Res 102: 1247-1255, 2008.
15. Dora KA, Sandow SL, Gallagher NT, Takano H, Rummery NM, Hill CE, Garland CHC. Myoendothelial gap junctions may provide the pathway for EDHF in mouse mesenteric artery. J Vasc Res 40: 480-490, 2003.
16. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272, 1998.
17. Edwards G, Félétou M, Weston A. Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflügers Arch 459: 863-879, 2010.
18. Edwards G, Weston AH. Potassium and potassium clouds in endothelium- dependent hyperpolarizations. Pharmacol Res 49: 535-541, 2004.
19. +-channels suppresses EDHFmediated vasodilation. Br J Pharmacol 138: 594-601, 2003.
20. Elmoselhi AB, Butcher A, Samson SE, Grover AK. Free radicals uncouple the sodium pump in pig coronary artery. Am J Physiol Cell Physiol 266: C720-C728, 1994.
21. Félétou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 93: 515-524, 1988.
22. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
23. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci 16: 23-30, 1995.
24. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck JR, Campbell WB. 14,15-Epoxyeicosa-5(Z)-enoic acid-a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res 90: 1028-1036, 2002.
25. Gluais P, Edwards G, Weston AH, Falck JR, Vanhoutte PM, Félétou M. Role of SKCa and IKCa in endothelium-dependent hyperpolarizations of the guinea-pig isolated carotid artery. Br J Pharmacol 144: 477-485, 2005.
26. Goto K, Fujii K, Kansui Y, Abe I, Iida M. Critical role of gap junctions in endothelium-dependent hyperpolarization in rat mesenteric arteries. Clin Exp Pharmacol 29: 595-602, 2002.
27. +-ATPase activity. Am J Physiol Cell Physiol 282: C560-C566, 2002.
28. Haddy FJ, Vanhoutte PM, Feletou M. Role of potassium in regulating blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol 290: R546-R552, 2006.
29. Harno E, Edwards G, Geraghty AR, Ward DT, Dodd RH, Dauban P, Faure H, Ruat M, Weston AH. Evidence for the presence of GPRC6A receptors in rat mesenteric arteries. Cell Calcium 44: 210-219, 2008.
30. Hattori T, Kajikuri J, Katsuya H, Itoh T. Effects of H2O2 on membrane potential of smooth muscle cells in rabbit mesenteric resistance artery. Eur J Pharmacol 464: 101-109, 2003.
31. Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HHHW, Busse R, Schröder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51: 211-217, 2008.
32. + channels in rat mesenteric arteries. J Pharmacol Exp Ther 333: 210-217, 2010.
33. Hilgers RH, Webb RC. Reduced expression of SKCa and IKCa channel proteins in rat small mesenteric arteries during angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 292: H2275-H2284, 2007.
34. Isabelle M, Vergeade A, Moritz F, Dautreaux B, Henry JP, Lallemand F, Richard V, Mulder P, Thuillez C, Monteil C. NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. J Mol Cell Cardiol 42: 326-332, 2007.
35. +-ATPase. Am J Physiol Heart Circ Physiol 252: H252-H257, 1987.
36. Lamon BD, Zhang FF, Puri N, Brodsky SV, Goligorsky MS, Nasjletti A. Dual pathways of carbon monoxide-mediated vasoregulation: modulation by redox mechanisms. Circ Res 105: 775-783, 2009.
37. Laniadoschwartzman M, Abraham NG, Sacerdoti D, Escalante B, Mcgiff JC. Effect of acute and chronic treatment of tin on blood-pressure in spontaneously hypertensive rats. Tohoku J Exp Med 166: 85-91, 1992.
38. Li Z, Wang Y, Vanhoutte PM. Upregulation of heme oxygenase 1 by hemin impairs endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Hypertension 58: 926-934, 2011.
39. Matalon S, Hardiman KM, Jain L, Eaton DC, Kotlikoff M, Eu JP, Sun J, Meissner G, Stamler JS. Regulation of ion channel structure and function by reactive oxygen-nitrogen species. Am J Physiol Lung Cell Mol Physiol 285: L1184-L1189, 2003.
40. Matchkov VV, Moeller-Nielsen N, Dam VS, Nourian Z, Briggs Boedtkjer DM, Aalkjaer C. The alpha2 isoform of the Na,K-pump is important for intercellular communication, agonist-induced contraction, and EDHFlike response in rat mesenteric arteries. Am J Physiol Heart Circ Physiol 303: H36-H46, 2012.
41. Matchkov VV, Rahman A, Bakker LM, Griffith TM, Nilsson H, Aalkjaer C. Analysis of effects of connexin-mimetic peptides in rat mesenteric small arteries. Am J Physiol Heart Circ Physiol 291: H357-H367, 2006.
42. Matoba T, Shimokawa H. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans. J Pharmacol Sci 92: 1-6, 2003.
43. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 290: 909-913, 2002.
44. Murphy ME, Brayden JE. Nitric-oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J Physiol 486: 47-58, 1995.
45. Nath KA, Grande JP, Farrugia G, Croatt AJ, Belcher JD, Hebbel RP, Vercellotti GM, Katusic ZS. Age sensitizes the kidney to heme proteininduced acute kidney injury. Am J Physiol Renal Physiol 304: F317-F325, 2013.
46. Nath KA, Katusic ZS. Vasculature and kidney complications in sickle cell disease. J Am Soc Nephrol 23: 781-784, 2012.
47. Ndisang JF, Wu LY, Zhao WM, Wang R. Induction of heme oxygenase- 1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats. Blood 101: 3893-3900, 2003.
48. Peterson SJ, Frishman WH. Targeting heme oxygenase therapeutic implications for diseases of the cardiovascular system. Cardiol Rev 17: 99-111, 2009.
49. Qian Q, Nath KA, Wu Y, Daoud TM, Sethi S. Hemolysis and acute kidney failure. Am J Kidney Dis 56: 780-784, 2010.
50. Ryter SW, Alam J, Choi AMK. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650, 2006.
51. Sacerdoti D, Escalante B, Abraham N, McGiff J, Levere R, Schwartzman M. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 243: 388-390, 1989.
52. Seki T, Naruse M, Naruse K, Yoshimoto T, Tanabe A, Tsuchiya K, Hirose S, Imaki T, Nihei H, Demura H. Roles of heme oxygenase carbon monoxide system in genetically hypertensive rats. Biochem Biophys Res Commun 241: 574-578, 1997.
53. Sesti F, Liu S, Cai SQ. Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration? Trends Cell Biol 20: 45-51, 2010.
54. Shamloul R, Wang R. Monitoring circulatory heme level in hemin therapy for lowering blood pressure in rats. Cell Mol Biol 51: 507-512, 2005.
55. + ATPase by oxyradical generating systems. Mol Cell Biochem 147: 139-144, 1995.
56. Sobey CG, Faraci FM. Knockout blow for channel identity crisis- vasodilation to potassium is mediated via Kir2.1. Circ Res 87: 83-84, 2000.
57. Stocker R, Yamamoto Y, McDonagh A, Glazer A, Ames B. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
58. Sun H, Fang Q, Mayhan WG. Inward rectifier potassium channels in the basilar artery during chronic alcohol consumption. Alcoholism: Clin Exper Res 28: 1557-1561, 2004.
59. Taillé C, El-Benna J, Lanone S, Dang MC, Ogier-Denis E, Aubier M, Boczkowski J. Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability. J Biol Chem 279: 28681-28688, 2004.
60. Tang EH, Vanhoutte PM. Gap junction inhibitors reduce endotheliumdependent contractions in the aorta of spontaneously hypertensive rats. J Pharmacol Exp Ther 327: 148-153, 2008.
61. Tang EHC, Leung FP, Huang Y, Félétou M, So KF, Man RYK, Vanhoutte PM. Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. Br J Pharmacol 151: 15-23, 2007.
62. Wang R, Shamloul R, Wang XX, Meng QH, Wu LY. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 48: 685-692, 2006.
63. Wang R, Wu L. The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 272: 8222-8226, 1997.
64. Wang R, Wu L. Interaction of selective amino acid residues of KCa channels with carbon monoxide. Exp Biol Med 228: 474-480, 2003.
65. Weston AH, Porter EL, Harno E, Edwards G. Impairment of endothelial SKCa channels and of downstream hyperpolarizing pathways in mesenteric arteries from spontaneously hypertensive rats. Br J Pharmacol 160: 836-843, 2010.
66. +-ATPases. Br J Pharmacol 136: 918-926, 2002.
67. Yang C, Kwan YW, Chan SW, Lee SM, Leung GP. Potentiation of EDHF-mediated relaxation by chloride channel blockers. Acta Pharmacol Sin 31: 1303-1311, 2010.
68. Yang GD, Wu LY, Jiang B, Yang W, Qi JS, Cao K, Meng QH, Mustafa AK, Mu WT, Zhang SM, Snyder SH, Wang R. H(2)S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590, 2008.
69. Zhao Y, Vanhoutte P, Leung S. Endothelial nitric oxide synthaseindependent release of nitric oxide in the aorta of the spontaneously hypertensive rat. J Pharmacol Exp Ther 344: 15-22, 2013.